Testosterone replacement therapy can worsen obstructive sleep apnea in some men, especially at higher doses in the first few months of treatment, which is why the Endocrine Society recommends against starting TRT in men with untreated severe sleep apnea. At the same time, untreated sleep apnea itself lowers testosterone, which means the two conditions can trap a man in a cycle where neither one gets diagnosed first.
Does TRT cause sleep apnea?
TRT does not typically cause sleep apnea from scratch in a man with a normal airway, but it can unmask or worsen the condition in men who already have risk factors like obesity, a thick neck, or an existing mild case that was never diagnosed. FDA prescribing information for testosterone products carries a warning that testosterone therapy may potentiate sleep apnea in patients with risk factors such as obesity or chronic lung disease, and the agency's most recent class-wide labeling review of testosterone products kept that caution in place (FDA, 2025).
Real-world data backs this up, though the increase is modest rather than dramatic. In one large retrospective analysis of over 6,400 hypogonadal men, about 14% of patients who started TRT were later diagnosed with obstructive sleep apnea, compared with a 12% baseline rate of OSA among men with hypogonadism who had not yet started treatment (American Urological Association, 2024). That is a real signal, not a coincidence, but it also means the large majority of men on TRT do not develop new sleep apnea.
Why testosterone affects breathing during sleep
The mechanism is not fully settled, but researchers generally point to a few overlapping effects. Testosterone can increase muscle mass in the neck and upper airway, alter fluid distribution around the throat, and shift how sensitively the brainstem responds to rising carbon dioxide during sleep, all of which can make the airway more prone to collapsing. A 2023 review in the journal Andrology found the effect was dose- and time-dependent: short-term, high-dose testosterone measurably worsened breathing during sleep in clinical studies, with one trial showing a roughly 10-point rise in the oxygen desaturation index after seven weeks of treatment, while longer-term therapy at lower, steady-state doses did not show the same worsening and may even improve symptoms over time (La Vignera et al., 2020).
The other direction: how sleep apnea lowers testosterone
The relationship runs both ways. Obstructive sleep apnea fragments sleep, causes repeated overnight drops in blood oxygen, and disrupts the deep and REM sleep stages when the body does most of its testosterone production. Multiple studies in severely obese men have found obstructive sleep apnea independently associated with lower total and free testosterone, even after adjusting for body weight (National Institutes of Health, 2021). That overlap explains why so many men who ask about TRT for fatigue, low libido, and brain fog are describing symptoms that could just as easily be undiagnosed sleep apnea, or both conditions at once.
What screening looks like before you start TRT
A responsible provider will ask about snoring, witnessed pauses in breathing, morning headaches, and daytime sleepiness before writing a testosterone prescription, particularly if you carry known risk factors like a BMI over 30, a large neck circumference, or a history of loud snoring reported by a partner. Men who screen positive for likely sleep apnea are typically referred for a sleep study, either an at-home test or an in-lab polysomnogram, before starting hormone therapy. The Endocrine Society's clinical practice guideline lists untreated severe obstructive sleep apnea as a condition where testosterone therapy should not be started, and recommends treating the sleep apnea first (Bhasin et al., Journal of Clinical Endocrinology & Metabolism, 2018). For men with mild or already-treated sleep apnea, most guidelines support proceeding with TRT under closer monitoring rather than ruling it out entirely.
